Insilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and developing innovative oncology therapies, by combining Insilico's AI-driven drug discovery platforms with Servier's global expertise in cancer drug development. Under...
Hence then, the article about insilico medicine announce us 888 million multi year collaboration with servier for drug discovery and development in oncology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Insilico Medicine Announce US$888 Million Multi-Year Collaboration with Servier for Drug Discovery and Development in Oncology )
Also on site :
- Dispatch centers in Marin County down, service outage reported for 911 calls
- Hawaiian Airlines announces Kahu'ewai Hawai'i Investment Plan of more than $600M over five years to modernize infrastructure and guest experience, and deepen its commitment to the community and sustainability
- ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis